Home › Companies › Boston Scientific Corporation › 2025-2026

Boston Scientific Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Boston Scientific Corporation’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

28Reported items
1,272Asset managers
21,280Fund votes
2026-04-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Boston Scientific Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Boston Scientific Corporation

These tallies are Boston Scientific Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Boston Scientific Corporation — official shareholder meeting results, meeting held 2026-04-30
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: David C. Habiger	1,037,805,652	169,730,106	2,858,635	--	81,271,529	Majority: yes
Elect Director: Edward J. Ludwig	1,156,469,560	50,835,636	3,089,197	--	81,271,529	Majority: yes
Elect Director: Michael F. Mahoney	1,113,612,016	93,613,027	3,169,350	--	81,271,529	Majority: yes
Elect Director: Jessica L. Mega	1,196,020,676	11,532,045	2,841,672	--	81,271,529	Majority: yes
Elect Director: Susan E. Morano	1,171,890,417	35,662,932	1,841,044	--	81,271,529	Majority: yes
Elect Director: Cheryl Pegus	1,195,889,562	11,653,832	2,850,999	--	81,271,529	Majority: yes
Elect Director: Cathy R. Smith	1,117,908,896	88,044,911	4,440,586	--	81,271,529	Majority: yes
Elect Director: Christophe P. Weber	1,205,365,637	2,260,256	2,768,500	--	81,271,529	Majority: yes
Elect Director: David S. Wichmann	1,198,736,185	8,393,038	3,265,170	--	81,271,529	Majority: yes
Elect Director: Ellen M. Zane	1,150,092,668	56,753,553	3,548,172	--	81,271,529	Majority: yes
(2) The stockholders approved, on an advisory basis, the compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting.	1,096,889,576	110,645,813	2,859,004	--	81,271,529	Majority: yes
(3) The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.	1,169,955,769	116,874,243	4,835,910	--	0	Majority: yes
(4) The stockholders approved the amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance.	1,205,130,032	2,818,667	2,445,694	--	81,271,529	Majority: yes
(5) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions.	1,189,271,431	17,774,053	3,348,909	--	81,271,529	Majority: yes
(6) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.	1,057,086,923	150,458,633	2,848,837	--	81,271,529	Majority: yes
(8) The stockholders did not approve the stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."	516,140,863	689,739,605	4,513,925	--	81,271,529	Majority: no

Source: Boston Scientific Corporation, Form 8-K — read the filing on EDGAR.

How asset managers voted at the Boston Scientific Corporation 2025-2026 meeting

Each item below shows how the 1,272 asset managers that disclosed a Boston Scientific Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Boston Scientific Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 29 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 1,096,889,576AGAINST: 110,645,813

Boston Scientific Corporation’s own tally for this item (“(2) The stockholders approved, on an advisory basis, the compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting.”): 1,096,889,576 for, 110,645,813 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 74% for, 7% against (81% of the company cast a for/against vote).

The 1,247 asset managers below cast 93% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 93%

FOR: 93.3%AGAINST: 6.6%ABSTAIN: 0.1%NOT VOTED: 0.0%UNKNOWN: 0.0%

Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	181,024,949	589	15	For
Fidelity	177,740,936	0	0	For
BlackRock	115,172,383	5,871	0	For
State Street	42,238,066	463,415	0	For
GEODE CAPITAL MANAGEMENT, LLC	33,079,391	0	0	For
Janus Henderson	32,546,057	49,734	0	For
PRIMECAP MANAGEMENT CO/CA/	31,580,364	0	0	For
Capital Group	31,536,628	0	0	For
Invesco	30,666,437	0	0	For
Putnam	23,312,633	0	0	For
Charles Schwab	17,589,853	0	0	For
UBS	16,573,322	547,813	0	For
Parnassus	14,805,895	0	0	For
Amundi	0	13,822,851	0	Against
Wellington	12,766,197	0	0	For
T. Rowe Price	12,166,200	50,438	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	12,082,671	0	0	For
Goldman Sachs	12,040,834	0	0	For
Union Investment Management GmbH	0	11,973,403	0	Against
Nuveen	11,698,030	694	0	For
DE Shaw	11,514,401	0	0	For
TIAA	11,111,512	0	0	For
Northern Trust	10,988,811	82,943	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
JPMorgan	9,542,397	0	0	For

Showing the 25 largest of 1,247 asset managers. See all 1,247 in the interactive database.

2. To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.

CAPITAL STRUCTUREMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 7 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 1,205,130,032AGAINST: 2,818,667

Boston Scientific Corporation’s own tally for this item (“(4) The stockholders approved the amendment of the Company's Employee Stock Purchase Plan to increase the number of shares reserved for issuance.”): 1,205,130,032 for, 2,818,667 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 81% for, 0.2% against (81% of the company cast a for/against vote).

The 225 asset managers below cast 99.9% of the shares they voted on this item FOR (480,508,074 for, 151,281 against).

FOR 99.9%

FOR: 480,508,074 (100.0%)AGAINST: 151,281 (0.0%)ABSTAIN: 10 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,898	15	10	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
Navera Investment Management Ltd.	1,615,514	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For

Showing the 25 largest of 225 asset managers. See all 225 in the interactive database.

3. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 1,169,955,769AGAINST: 116,874,243

Boston Scientific Corporation’s own tally for this item (“(3) The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.”): 1,169,955,769 for, 116,874,243 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 79% for, 8% against (87% of the company cast a for/against vote).

The 210 asset managers below cast 99.4% of the shares they voted on this item FOR (475,068,164 for, 2,595,580 against).

FOR 99.4%

FOR: 475,068,164 (99.4%)AGAINST: 2,595,580 (0.5%)ABSTAIN: 142,679 (0.0%)UNKNOWN: 24,011 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 20” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,882,980	116,922	24	For
Fidelity	97,056,397	119,959	0	For
BlackRock	47,752,848	8,529	0	For
State Street	18,264,131	209	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,542,413	22,548	0	For

Showing the 25 largest of 210 asset managers. See all 210 in the interactive database.

4. Proposal to elect ten Directors: David C. Habiger

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%AGAINST 14%

FOR: 1,037,805,652AGAINST: 169,730,106

Boston Scientific Corporation’s own tally for this item (“Elect Director: David C. Habiger”): 1,037,805,652 for, 169,730,106 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 70% for, 11% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 93% of the shares they voted on this item FOR (444,992,440 for, 32,670,409 against).

FOR 93%

FOR: 444,992,440 (93.1%)AGAINST: 32,670,409 (6.8%)ABSTAIN: 142,670 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: David C. Habiger” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	155,269,860	10,730,048	15	For
Fidelity	97,156,092	20,264	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	0	16,587,637	0	Against
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	0	2,393,727	0	Against
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,542,413	22,548	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

5. Proposal to elect ten Directors: Edward J. Ludwig

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 1,156,469,560AGAINST: 50,835,636

Boston Scientific Corporation’s own tally for this item (“Elect Director: Edward J. Ludwig”): 1,156,469,560 for, 50,835,636 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 78% for, 3% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,212,029 for, 450,820 against).

FOR 99.8%

FOR: 477,212,029 (99.9%)AGAINST: 450,820 (0.1%)ABSTAIN: 142,672 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Edward J. Ludwig” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,660	248	17	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,131	209	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

6. Proposal to elect ten Directors: Michael F. Mahoney

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 1,113,612,016AGAINST: 93,613,027

Boston Scientific Corporation’s own tally for this item (“Elect Director: Michael F. Mahoney”): 1,113,612,016 for, 93,613,027 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 75% for, 6% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,631,074 for, 31,777 against).

FOR 99.9%

FOR: 477,631,074 (100.0%)AGAINST: 31,777 (0.0%)ABSTAIN: 142,670 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Michael F. Mahoney” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,408	502	15	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,224	116	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,542,413	22,548	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

7. Proposal to elect ten Directors: Jessica L. Mega

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%

FOR: 1,196,020,676AGAINST: 11,532,045

Boston Scientific Corporation’s own tally for this item (“Elect Director: Jessica L. Mega”): 1,196,020,676 for, 11,532,045 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 80% for, 0.8% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,530,242 for, 132,605 against).

FOR 99.9%

FOR: 477,530,242 (99.9%)AGAINST: 132,605 (0.0%)ABSTAIN: 142,669 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Jessica L. Mega” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,877	29	14	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

8. Proposal to elect ten Directors: Susan E. Morano

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 1,171,890,417AGAINST: 35,662,932

Boston Scientific Corporation’s own tally for this item (“Elect Director: Susan E. Morano”): 1,171,890,417 for, 35,662,932 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 79% for, 2% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.8% of the shares they voted on this item FOR (477,028,420 for, 634,431 against).

FOR 99.8%

FOR: 477,028,420 (99.8%)AGAINST: 634,431 (0.1%)ABSTAIN: 142,670 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Susan E. Morano” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,883,457	116,455	15	For
Fidelity	97,176,356	0	0	For
BlackRock	47,752,848	8,529	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

9. Proposal to elect ten Directors: Cheryl Pegus

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%

FOR: 1,195,889,562AGAINST: 11,653,832

Boston Scientific Corporation’s own tally for this item (“Elect Director: Cheryl Pegus”): 1,195,889,562 for, 11,653,832 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 80% for, 0.8% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,530,242 for, 132,606 against).

FOR 99.9%

FOR: 477,530,242 (99.9%)AGAINST: 132,606 (0.0%)ABSTAIN: 142,669 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Cheryl Pegus” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,877	30	14	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

10. Proposal to elect ten Directors: Cathy R. Smith

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 7 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%

FOR: 1,117,908,896AGAINST: 88,044,911

Boston Scientific Corporation’s own tally for this item (“Elect Director: Cathy R. Smith”): 1,117,908,896 for, 88,044,911 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 75% for, 6% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 96% of the shares they voted on this item FOR (459,039,494 for, 18,623,346 against).

FOR 96%

FOR: 459,039,494 (96.1%)AGAINST: 18,623,346 (3.9%)ABSTAIN: 142,680 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Cathy R. Smith” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,883,103	116,798	25	For
Fidelity	97,176,356	0	0	For
BlackRock	47,745,017	16,360	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	7,193	8,681,824	0	Against
Parnassus	0	7,000,646	0	Against
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,542,413	22,548	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

11. Proposal to elect ten Directors: Christophe P. Weber

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 1,205,365,637AGAINST: 2,260,256

Boston Scientific Corporation’s own tally for this item (“Elect Director: Christophe P. Weber”): 1,205,365,637 for, 2,260,256 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 81% for, 0.2% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,637,842 for, 25,009 against).

FOR 99.9%

FOR: 477,637,842 (100.0%)AGAINST: 25,009 (0.0%)ABSTAIN: 142,668 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Christophe P. Weber” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,901	9	13	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

12. Proposal to elect ten Directors: David S. Wichmann

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 1,198,736,185AGAINST: 8,393,038

Boston Scientific Corporation’s own tally for this item (“Elect Director: David S. Wichmann”): 1,198,736,185 for, 8,393,038 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 81% for, 0.6% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,572,623 for, 90,226 against).

FOR 99.9%

FOR: 477,572,623 (99.9%)AGAINST: 90,226 (0.0%)ABSTAIN: 142,670 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: David S. Wichmann” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,870	38	15	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

13. Proposal to elect ten Directors: Ellen M. Zane

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 1,150,092,668AGAINST: 56,753,553

Boston Scientific Corporation’s own tally for this item (“Elect Director: Ellen M. Zane”): 1,150,092,668 for, 56,753,553 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 77% for, 4% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 99.9% of the shares they voted on this item FOR (477,214,364 for, 448,480 against).

FOR 99.8%

FOR: 477,214,364 (99.9%)AGAINST: 448,480 (0.1%)ABSTAIN: 142,673 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Proposal to elect ten Directors: Ellen M. Zane” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,636	267	18	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

14. To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%

FOR: 1,057,086,923AGAINST: 150,458,633

Boston Scientific Corporation’s own tally for this item (“(6) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.”): 1,057,086,923 for, 150,458,633 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 71% for, 10% against (81% of the company cast a for/against vote).

The 209 asset managers below cast 95% of the shares they voted on this item FOR (455,686,001 for, 21,951,848 against).

FOR 95%

FOR: 455,686,001 (95.4%)AGAINST: 21,951,848 (4.6%)ABSTAIN: 167,670 (0.0%)UNKNOWN: 24,198 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaw” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,882,802	117,107	15	For
Fidelity	97,176,356	0	0	For
BlackRock	47,720,154	41,223	0	For
State Street	18,262,601	1,739	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	0	8,850,564	0	Against
Charles Schwab	8,686,495	2,522	0	For
Parnassus	0	7,000,646	0	Against
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,491,857	196,423	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	0	1,605,985	0	Against
Equitable	1,564,961	0	0	For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

15. Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: no

Meeting held 2026-04-30.

Combines 8 wordings of this item as funds reported it.

43% Majority: no · of votes cast

FOR 43%AGAINST 57%

FOR: 516,140,863AGAINST: 689,739,605

Boston Scientific Corporation’s own tally for this item (“(8) The stockholders did not approve the stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."”): 516,140,863 for, 689,739,605 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 35% for, 46.4% against (81% of the company cast a for/against vote).

The 208 asset managers below cast 17% of the shares they voted on this item FOR (79,987,354 for, 396,960,735 against).

FOR 17%AGAINST 83%

FOR: 79,987,354 (16.8%)AGAINST: 396,960,735 (83.2%)ABSTAIN: 142,680 (0.0%)UNKNOWN: 25,007 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	11,626,825	154,373,075	25	Against
Fidelity	1,264,983	95,911,373	0	Against
BlackRock	79,115	47,682,262	0	Against
State Street	35,887	18,228,453	0	Against
Capital Group	16,587,637	0	0	For
TIAA	0	11,025,511	0	Against
JANUS INVESTMENT FUND	7,545,466	3,077,904	0	For
Putnam	0	9,521,641	0	Against
Invesco	4,742,850	4,242,861	0	For
JPMorgan	0	8,850,564	0	Against
Charles Schwab	2,522	8,686,495	0	Against
Parnassus	7,000,646	0	0	For
MFS	0	5,192,491	0	Against
ADVISORS' INNER CIRCLE FUND	74,618	3,337,599	0	Against
Dimensional	0	3,064,670	0	Against
T. Rowe Price	0	3,044,758	0	Against
Jackson National	1,485,671	1,202,609	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	0	2,413,436	0	Against
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	0	2,307,126	0	Against
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	0	1,606,600	0	Against
Neuberger Berman	0	1,605,985	0	Against
Equitable	1,184,088	380,873	0	For

Showing the 25 largest of 208 asset managers. See all 208 in the interactive database.

16. To amend our Certificate of Incorporation to remove supermajority voting provisions.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2026-04-30.

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 1,189,271,431AGAINST: 17,774,053

Boston Scientific Corporation’s own tally for this item (“(5) The stockholders approved the amendment of the Company's Third Restated Certificate of Incorporation to remove supermajority voting provisions.”): 1,189,271,431 for, 17,774,053 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 80% for, 1% against (81% of the company cast a for/against vote).

The 203 asset managers below cast 99.9% of the shares they voted on this item FOR (476,415,404 for, 50,103 against).

FOR 99.9%

FOR: 476,415,404 (100.0%)AGAINST: 50,103 (0.0%)ABSTAIN: 18 (0.0%)UNKNOWN: 24,011 (0.0%)NOT VOTED: 1,125 (0.0%)

Largest asset managers voting on “To amend our Certificate of Incorporation to remove supermajority voting provisions.” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	165,999,803	103	18	For
Fidelity	97,176,356	0	0	For
BlackRock	47,761,377	0	0	For
State Street	18,264,340	0	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,689,017	0	0	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	1,606,600	0	0	For
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 203 asset managers. See all 203 in the interactive database.

17. To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders.

CORPORATE GOVERNANCE

Meeting held 2026-04-30.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 93%7%

The 203 asset managers below cast 99.9% of the shares they voted on this item FOR (442,213,390 for, 328,263 against).

FOR: 442,213,390 (92.8%)AGAINST: 328,263 (0.1%)ABSTAIN: 33,923,684 (7.1%)UNKNOWN: 24,011 (0.0%)NOT VOTED: 1,125 (0.0%)A: 187 (0.0%)

Largest asset managers voting on “To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock t” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	136,296,214	203,763	29,499,947	For
Fidelity	97,176,356	0	0	For
BlackRock	47,719,106	25,911	16,360	For
State Street	18,234,526	29,814	0	For
Capital Group	16,587,637	0	0	For
TIAA	11,025,511	0	0	For
JANUS INVESTMENT FUND	10,623,370	0	0	For
Putnam	9,521,641	0	0	For
Invesco	8,985,711	0	0	For
JPMorgan	8,850,564	0	0	For
Charles Schwab	8,686,495	0	2,522	For
Parnassus	7,000,646	0	0	For
MFS	5,192,491	0	0	For
ADVISORS' INNER CIRCLE FUND	3,412,217	0	0	For
Dimensional	3,064,670	0	0	For
T. Rowe Price	3,044,758	0	0	For
Jackson National	2,688,280	0	0	For
Columbia Threadneedle	2,629,510	0	0	For
MASSACHUSETTS INVESTORS GROWTH STOCK FUND	2,413,436	0	0	For
NEW ECONOMY FUND	2,393,727	0	0	For
MASTER INVESTMENT PORTFOLIO	2,307,126	0	0	For
Eaton Vance	1,680,678	0	0	For
PRIMECAP Odyssey Funds	0	0	1,606,600	Abstain
Neuberger Berman	1,605,985	0	0	For
Equitable	1,564,961	0	0	For

Showing the 25 largest of 203 asset managers. See all 203 in the interactive database.

18. Provide Right to Call a Special Meeting at a 10 Percent Ownership Threshold

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2026-04-30.

87% fund support · no official result

FOR 87%13%

The 6 asset managers below cast 87% of the shares they voted on this item FOR (625,022 for, 90,863 against).

FOR: 625,022 (87.3%)AGAINST: 90,863 (12.7%)

Largest asset managers voting on “Provide Right to Call a Special Meeting at a 10 Percent Ownership Threshold” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Vote
Empower	239,364	90,863	For
Brighthouse	169,564	0	For
Erste Asset Management GmbH	163,458	0	For
Eleva Capital SAS	26,667	0	For
CLEARWATER INVESTMENT TRUST	25,701	0	For
WORMSER FRERES GESTION	268	0	For

19. Eliminate Supermajority Vote Requirements

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2026-04-30.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (715,617 for, 0 against).

FOR: 715,617 (100.0%)

Largest asset managers voting on “Eliminate Supermajority Vote Requirements” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Vote
Empower	330,227	For
Brighthouse	169,564	For
Erste Asset Management GmbH	163,458	For
Eleva Capital SAS	26,667	For
CLEARWATER INVESTMENT TRUST	25,701	For

20. Provide Right to Call a Special Meeting at a 25 Percent Ownership Threshold

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2026-04-30.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (715,617 for, 0 against).

FOR: 715,617 (100.0%)

Largest asset managers voting on “Provide Right to Call a Special Meeting at a 25 Percent Ownership Threshold” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Vote
Empower	330,227	For
Brighthouse	169,564	For
Erste Asset Management GmbH	163,458	For
Eleva Capital SAS	26,667	For
CLEARWATER INVESTMENT TRUST	25,701	For

21. To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-01 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 1,139,414,439AGAINST: 100,849,233

Boston Scientific Corporation’s own tally for this item (“(2) The stockholders approved, on an advisory basis, the compensation of the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting.”): 1,139,414,439 for, 100,849,233 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,486,355,179 outstanding shares: 77% for, 7% against (83% of the company cast a for/against vote).

The 5 asset managers below cast 9% of the shares they voted on this item FOR (93,521 for, 908,320 against).

9%AGAINST 91%

FOR: 93,521 (9.3%)AGAINST: 908,320 (90.7%)

Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Vote
OSSIAM	0	753,807	Against
PENSIOENFONDS RAIL & OV	0	154,513	Against
Investment Management Corp of Ontario	90,900	0	For
GLENMEDE FUND INC	1,331	0	For
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC	1,290	0	For

22. To approve, on a non-binding advisory basis, the compensation of our named executive officers

SECTION 14A SAY-ON-PAY VOTES

Reported under meeting date 2026-04-20; no official results on file for that date.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (29,498 for, 0 against).

FOR: 29,498 (100.0%)

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation of our named executive officers” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Vote
Brighthouse	18,837	For
PARTHENON LLC	10,509	For
Ironwood Investment Counsel, LLC	152	For

23. Adoption of Right to Call a Special Meeting

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: no

Meeting held 2026-04-30.

43% Majority: no · of votes cast

FOR 43%AGAINST 57%

FOR: 516,140,863AGAINST: 689,739,605

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ABSTAIN 100%

ABSTAIN: 623,577 (100.0%)

Largest asset managers voting on “Adoption of Right to Call a Special Meeting” at Boston Scientific Corporation, 2025-2026
Asset manager	Abstain	Vote
Cardano Risk Management B.V.	621,600	Abstain
Northern Lights Fund Trust IV	1,592	Abstain
PACE SELECT ADVISORS TRUST	385	Abstain

24. Elimination of Supermajority Requirement

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2026-04-30.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (623,577 for, 0 against).

FOR: 623,577 (100.0%)

Largest asset managers voting on “Elimination of Supermajority Requirement” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Vote
Cardano Risk Management B.V.	621,600	For
Northern Lights Fund Trust IV	1,592	For
PACE SELECT ADVISORS TRUST	385	For

25. Say on Pay

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-04-30.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 1,096,889,576AGAINST: 110,645,813

The 3 asset managers below cast 97% of the shares they voted on this item FOR (98,123 for, 2,560 against).

FOR 97%

FOR: 98,123 (97.5%)AGAINST: 2,560 (2.5%)

Largest asset managers voting on “Say on Pay” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Vote
Empower	98,058	0	For
Genus Capital Management Inc.	0	2,560	Against
Arista Wealth Management, LLC	65	0	For

26. To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Reported under meeting date 2026-03-06; no official results on file for that date.

0.1% fund support · no official result

AGAINST 99.9%

The 2 asset managers below cast 0.1% of the shares they voted on this item FOR (2,513 for, 6,182,570 against).

FOR: 2,513 (0.0%)AGAINST: 6,182,570 (100.0%)

Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
SCHRODER INVESTMENT MANAGEMENT GROUP	0	6,182,570	0	0	Against
GLOBALT Investments LLC / GA	2,513	0	0	0	For

27. Corporate governance

CORPORATE GOVERNANCE

Meeting held 2026-04-30.

Combines 2 wordings of this item as funds reported it.

40% fund support · no official result

FOR 40%AGAINST 60%

The 2 asset managers below cast 40% of the shares they voted on this item FOR (477 for, 715 against).

FOR: 477 (40.0%)AGAINST: 715 (60.0%)

Largest asset managers voting on “Corporate governance” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
McGowan Group Asset Management, Inc.	0	715	0	0	Against
Members Trust Co	477	0	0	0	For

28. Eliminate Supermajority Requirements

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2026-04-30.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,435 for, 0 against).

FOR: 1,435 (100.0%)

Largest asset managers voting on “Eliminate Supermajority Requirements” at Boston Scientific Corporation, 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
MARCO INVESTMENT MANAGEMENT LLC	720	0	0	0	For
McGowan Group Asset Management, Inc.	715	0	0	0	For

Largest Boston Scientific Corporation shareholders voting in 2025-2026

Ranked by the number of Boston Scientific Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 1,486,355,179 shares outstanding at the time of that meeting.

Top Boston Scientific Corporation shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Vanguard	12.18%
2	Fidelity	11.96%
3	BlackRock	7.75%
4	State Street	2.87%
5	GEODE CAPITAL MANAGEMENT, LLC	2.23%
6	Janus Henderson	2.19%
7	PRIMECAP MANAGEMENT CO/CA/	2.12%
8	Capital Group	2.12%
9	Invesco	2.06%
10	Putnam	1.57%

Reported Boston Scientific Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Boston Scientific Corporation beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	8.87%	13F
FMR (Fidelity)	4.99%	13F
State Street	4.57%	13F
JPMorgan Chase	2.24%	13F
D.E. Shaw	1.64%	13F
Morgan Stanley	1.54%	13F
Goldman Sachs	1.30%	13F
Wellington Management	1.27%	13F

Percentages above are of 1,486,355,179 shares outstanding, as reported by Boston Scientific Corporation on its Form 10-Q dated 2026-04-29 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Boston Scientific Corporation’s 10-Q dated 2026-04-29. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Boston Scientific Corporation's shareholder meeting held 2026-04-30, in the 2025-2026 proxy season, 1,272 asset managers reported how they voted in their SEC Form N-PX filings, covering 21,280 separate fund positions. Their filings are grouped here into 28 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Boston Scientific Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

Boston Scientific Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).